Trial Details

Authorised
Basic Information
Clinical ID c5076
Identifier EUCTR2018-002925-47-ES
Trial Title Identification of predictive biomarkers for response to biologic therapies in inflammatory bowel disease by proteomic and mass cytometry approaches
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory bowel disease . MedDRA version: 20.1. Level: LLT. Classification code 10045365. Term: Ulcerative colitis. System Organ Clas
Interventions Trade Name: Adalimumab Pharmaceutical Form: Injection INN or Proposed INN: ADALIMUMAB CAS Number: 331731-18-1 Concentration unit: mg milligram(s)
Participant Information
Sponsor Fundacin de Investigacin Biomica del Hospital Universitario de La Princesa
City NULL
Country/Region Spain
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL